Lexicon Pharmaceuticals, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-123.0M | $-131.4M | $-4.7M | $-100.3M | $-104.1M | $-110.2M | $-116.2M | $-101.8M |
| Depreciation & Amortization | $3.4M | $2.1M | $727.0K | $1.9M | $2.9M | $4.2M | $4.9M | $5.4M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $1.5M | — | — | — | — | — | — | — |
| Stock-Based Compensation | $9.5M | $7.5M | $6.8M | $7.1M | $7.4M | $6.5M | $5.7M | $5.5M |
| Net Cash from Operating Activities | $-185.4M | $-175.6M | $184.8M | $-75.6M | $-91.1M | $-94.5M | $-87.9M | $-82.4M |
| Investing Activities | ||||||||
| Capital Expenditures | $228.0K | $231.0K | $910.0K | $80.0K | $1.7M | $492.0K | $1.2M | $1.1M |
| Business Acquisitions | — | — | — | — | — | $0 | $0 | $5.6M |
| Net Cash from Investing Activities | $50.5M | $18.3M | $-117.0M | $-108.4M | $99.5M | $-97.8M | $70.0M | $-113.8M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $1.7M | $621.0K | $357.0K | $887.0K | $873.0K | $285.0K | $108.0K | $149.0K |
| Net Cash from Financing Activities | $149.9M | $987.0K | $-2.0M | $283.8M | $-1.4M | $36.4M | $157.1M | $142.9M |
| Net Change in Cash | $15.1M | $-156.4M | $65.7M | $99.8M | $7.1M | $-155.9M | $139.1M | $-53.3M |
| Free Cash Flow | $-185.6M | $-175.9M | $183.9M | $-75.7M | $-92.8M | $-95.0M | $-89.1M | $-83.5M |